Abstract |
In this study, we investigated the immune response following immunotherapy with calcitonin-pulsed dendritic cells (DC) in 7 patients with metastasized medullary thyroid carcinoma. After immunization with 1-5 x 10(6) autologous DC, significant calcitonin-specific T cell proliferation was detectable in 3 patients. Measurement of cytokine release from T lymphocytes demonstrated high post-treatment interferon-gamma (IFN-gamma) secretion after stimulation with calcitonin in 5 patients, one of whom experienced significant tumor regression. In contrast, antigen-specific interleukin-4 (IL-4) production was only slightly increased in 4 patients. All 7 patients developed a strong delayed-type hypersensitivity (DTH) skin reaction, which was confirmed to be mediated by infiltrating CD4+ T-helper cells and CD8+ cytotoxic T cells in all 3 patients who underwent skin biopsy. This is the first study to show that a polypeptide hormone can be used to develop a DC vaccination strategy for the immunotherapy of highly malignant endocrine cancers.
|
Authors | Matthias Schott, Joachim Feldkamp, Melanie Klucken, Guido Kobbe, Werner A Scherbaum, Jochen Seissler |
Journal | Cancer immunology, immunotherapy : CII
(Cancer Immunol Immunother)
Vol. 51
Issue 11-12
Pg. 663-8
(Dec 2002)
ISSN: 0340-7004 [Print] Germany |
PMID | 12439612
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Calcitonin
(immunology)
- Carcinoma, Medullary
(immunology, therapy)
- Cytokines
(biosynthesis)
- Dendritic Cells
(immunology)
- Female
- Humans
- Hypersensitivity, Delayed
(etiology)
- Immunohistochemistry
- Lymphocyte Activation
- Male
- Middle Aged
- T-Lymphocytes
(immunology)
- Thyroid Neoplasms
(immunology, therapy)
- Vaccination
|